JPRN-UMIN000005090已完成2 期
First line Therapy by Sorafenib for Lung Metastases Patients in Renal Cell Carcinoma - First line Therapy by Sorafenib for Lung Metastases Patients in Renal Cell Carcinoma
Kobe University Graduate school of Medicine0 个研究点目标入组 100 人开始时间: 2011年2月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have or have had thromboembolism and/or ischemic cardiac disease 2) Poorly controlled hypertension 3) Patients with serious hepatic function disorder 4) Patients who have or have had interstitial pulmonary disease 5) Pregnant or nursing patients 6) Patients being treated with other drugs for purpose of anti cancer treatment 7) Patients who may otherwise compromise subject safety in the conduct of the trial or who may compromise protocol compliance
研究者
相似试验
进行中（未招募）
不适用
Sorafenib in the first line treatment of advanced hepatocellular carcinoma with ChildPugh liver function class B. Multicentre phase 3 randomized trial - BOOSTadvanced hepatocellular carcinoma with ChildPugh liver function class BMedDRA version: 9.1Level: LLTClassification code 10024720EUCTR2009-013870-42-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE
已完成
2 期
Investigating the role of targeted therapy Sorafenib - the Fms-like tyrosine kinase 3 (FLT3) inhibitor, in combination with intensive chemotherapy, for previously untreated adult patients with Acute Myeloid Leukaemia (AML) with FLT3 mutations. A Phase II randomised placebo-controlled multi-centre studyPreviously untreated adult acute myeloid leukaemia (AML) with FLT3-ITD mutation.Cancer - Leukaemia - Acute leukaemiaACTRN12611001112954eukaemia Foundation of Australia98
进行中（未招募）
不适用
Phase II single agent sorafenib in the treatment of relapsed oesophageal/gastric adenocarcinoma in platinum pre-treated patients - Sorafenib upper GI studyEUCTR2008-005062-31-IEICORG, the all-Ireland Co-operative Oncology Research Group54
招募中
1 期
A phase I study of sorafenib/UFT chemotherapy in advanced hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000005335Kyushu Univrsity Hospital18
已完成
不适用
Sorafenib pharmacokinetics in non small cell lung cancer patients: an in;vivo study using positron emission tomographylung cancer10038666NL-OMON37648Vrije Universiteit Medisch Centrum12